Barrans Russell

SEC source: 0001618835-21-000158 · wf-form4_162586090669169.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 448,554

F1 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on July 8, 2021. No shares were sold in connection with this transaction.

SEC source: 0001618835-21-000150 · wf-form4_162345718004725.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 468,552

SEC source: 0001618835-21-000136 · wf-form4_162162878492815.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,372

F1 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 20, 2021. No shares were sold in connection with this transaction.

SEC source: 0001618835-21-000013 · wf-form4_161240053204351.xml · derivative · entry 3

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2031-02-03

F4 · derivative.exercise_date: The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 3, 2021.

SEC source: 0001618835-21-000013 · wf-form4_161240053204351.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 481,852

F1 · shares: The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2021.

F2 · balance_after: The total amount of securities beneficially owned includes 2,800 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on December 15, 2020, the last trading day of the purchase period.

SEC source: 0001618835-20-000220 · wf-form4_159985918676264.xml · nonDerivative · entry 2

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,052

SEC source: 0001618835-20-000220 · wf-form4_159985918676264.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,052

SEC source: 0001618835-20-000206 · wf-form4_159433301888130.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,052

F1 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on July 8, 2020. No shares were sold in connection with this transaction.

F2 · balance_after: The total amount of securities beneficially owned includes 1,924 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on June 12,2020, the last trading day of the purchase period.

SEC source: 0001618835-20-000186 · wf-form4_159165251807510.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,509

F1 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on June 5, 2020. No shares were sold in connection with this transaction.

SEC source: 0001618835-20-000156 · wf-form4_159052774810234.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,964

F1 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 22, 2020. No shares were sold in connection with this transaction.

SEC source: 0001618835-20-000115 · wf-form4_158895552459899.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,438

F1 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 6, 2020. No shares were sold in connection with this transaction.

SEC source: 0001618835-20-000027 · wf-form4_158231220248237.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,240

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019.

SEC source: 0001618835-20-000023 · wf-form4_158111121503365.xml · derivative · entry 4

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-02-05

F6 · derivative.exercise_date: The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 5, 2020.

SEC source: 0001618835-20-000023 · wf-form4_158111121503365.xml · nonDerivative · entry 2

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,197

F4 · shares: The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2020.

SEC source: 0001618835-20-000023 · wf-form4_158111121503365.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,197

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Evofem Biosciences, Inc. 2019 Employee Stock Purchase Plan (2019 ESPP), for the ESPP purchase period of June 17, 2019 through December 13,2019. This transaction is also exempt under Rule 16b-3(c).

F2 · date: The reporting person is voluntarily reporting this transaction as of February 5, 2020, but the actual transaction took place on December 13, 2019, the last trading day of the purchase period under the 2019 ESPP.

F3 · shares: In accordance with the 2019 ESPP, these shares were purchased based on 85% of the closing stock price on December 13, 2019, the last trading day of the purchase period.

SEC source: 0001618835-20-000013 · wf-form4_157963039010607.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,298

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019.

SEC source: 0001618835-19-000204 · wf-form4_157480650820263.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,876

F1 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on November 25, 2019. No shares were sold in connection with this transaction.

SEC source: 0001618835-19-000186 · wf-form4_157438553235620.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,153

F1 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on November 20, 2019. No shares were sold in connection with this transaction.

SEC source: 0001618835-19-000156 · wf-form4_156685900974033.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,197

F1 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on August 22, 2019. No shares were sold in connection with this transaction.

SEC source: 0001618835-19-000141 · wf-form4_156279996204676.xml · nonDerivative · entry 2

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,159

F2 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurred on July 8, 2019. No shares were sold in connection with this transaction.

SEC source: 0001618835-19-000141 · wf-form4_156279996204676.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,416

F1 · shares: The restricted stock awards shall vest in three equal installments on July 8, 2019, 2020 and 2021.

SEC source: 0001618835-19-000127 · wf-form4_156037197830004.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,416

F1 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on June 10, 2019. No shares were sold in connection with this transaction.

SEC source: 0001618835-19-000046 · wf-form4_155433119050577.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,381

F1 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on April 1, 2019. No shares were sold in connection with this transaction.

SEC source: 0001618835-19-000017 · wf-form4_155130177047358.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,541

F1 · shares: The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2019.

SEC source: 0001618835-18-000119 · wf-form4_154353308271905.xml · derivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 0 shares

Expires 2028-11-28

F1 · derivative.exercise_date: The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from November 28, 2018.

SEC source: 0001618835-18-000126 · wf-form4a_154385938921133.xml · derivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2028-11-28

F1 · shares: The original Form 4, filed on November 29, 2018, is being amended to update the number of shares reported in Column 5(A) and Column 7 of Table II.

F2 · derivative.exercise_date: The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from November 28, 2018.

F1 · derivative.underlying_shares: The original Form 4, filed on November 29, 2018, is being amended to update the number of shares reported in Column 5(A) and Column 7 of Table II.

SEC source: 0001618835-18-000109 · wf-form4_154326280693538.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · As custodian for child's UTMA account

Disclosed balance after: 12,820

F1 · ownership.nature: These securities were purchased by the reporting person as custodian for one minor child under the Uniform Transfers to Minors Act. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

SEC source: 0001618835-18-000084 · wf-form4_153420063886225.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,541

SEC source: 0001618835-18-000078 · wf-form4_153324142399394.xml · derivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,800

Underlying: Common Stock · 98,800 shares

Expires 2028-07-31

F1 · derivative.exercise_date: The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from July 31, 2018.

SEC source: 0001618835-18-000050 · wf-form4_153065177824486.xml · nonDerivative · entry 2

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,826

F2 · shares: Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on July 2, 2018. No shares were sold in connection with this transaction.

SEC source: 0001618835-18-000050 · wf-form4_153065177824486.xml · nonDerivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,666

F1 · shares: The restricted stock awards vested in full on July 2, 2018.

SEC source: 0001209191-18-019632 · doc4.xml · derivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,000

Underlying: Common Stock · 260,000 shares

Expires 2028-03-12

F1 · derivative.exercise_date: Mr. Barrans acquired a vested interest in 66.67% of the shares of common stock exercisable pursuant to the option effective as of March 12, 2018 (the "Vesting Start Date"). The remaining shares shall vest in a series of twelve (12) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from the Vesting Start Date. The option was awarded in connection with Mr. Barrans' service as Chief Commercial Officer.

SEC source: 0001209191-18-004293 · doc4.xml · derivative · entry 2

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,283

Underlying: Common Stock · 1,283 shares

Expires 2026-09-28

F1 · shares: On January 17, 2018, Issuer completed a merger transaction (the "Merger") pursuant to an Agreement and Plan of Merger and Reorganization, dated October 17, 2017, by and among Issuer, Nobelli Merger Sub, Inc., and Evofem Biosciences Operations, Inc., formerly known as Evofem Biosciences, Inc. ("Evofem Operations"), as filed with the Securities and Exchange Commission on Form 8-K on October 17, 2017 (the "Merger Agreement"). Pursuant to the Merger Agreement all issued and outstanding options of Evofem Operations converted into and became options to purchase shares of Issuer's common stock.

F2 · shares: These options to purchase common stock of Issuer were received in connection with the Merger in exchange for options to purchase shares of common stock of Evofem Operations. Each option to purchase one share of common stock of Evofem Operations was cancelled and exchanged for the right to receive an option to purchase 0.154 shares of common stock of Issuer. The shares of common stock of Issuer exercisable pursuant to the option reported reflect any necessary adjustments to account for the 6 for 1 reverse stock split effected by Issuer on January 17, 2018.

F2 · price: These options to purchase common stock of Issuer were received in connection with the Merger in exchange for options to purchase shares of common stock of Evofem Operations. Each option to purchase one share of common stock of Evofem Operations was cancelled and exchanged for the right to receive an option to purchase 0.154 shares of common stock of Issuer. The shares of common stock of Issuer exercisable pursuant to the option reported reflect any necessary adjustments to account for the 6 for 1 reverse stock split effected by Issuer on January 17, 2018.

F4 · derivative.exercise_date: Mr. Barrans acquired a vested interest in twenty-five percent (25%) of the shares of common stock exercisable pursuant to the option effective as of September 28, 2017 (the "Vesting Start Date"). The remaining shares shall vest in a series of thirty-six (36) successive equal monthly installments on the monthly anniversary of the Vesting Start Date, such that all shares of common stock of Issuer exercisable pursuant to the option shall be fully vested on September 28, 2020, subject to Mr. Barrans' continued service.

SEC source: 0001209191-18-004293 · doc4.xml · derivative · entry 1

Barrans Russell · CIK 0001726184 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,850

Underlying: Common Stock · 3,850 shares

Expires 2026-09-28

F1 · shares: On January 17, 2018, Issuer completed a merger transaction (the "Merger") pursuant to an Agreement and Plan of Merger and Reorganization, dated October 17, 2017, by and among Issuer, Nobelli Merger Sub, Inc., and Evofem Biosciences Operations, Inc., formerly known as Evofem Biosciences, Inc. ("Evofem Operations"), as filed with the Securities and Exchange Commission on Form 8-K on October 17, 2017 (the "Merger Agreement"). Pursuant to the Merger Agreement all issued and outstanding options of Evofem Operations converted into and became options to purchase shares of Issuer's common stock.

F2 · shares: These options to purchase common stock of Issuer were received in connection with the Merger in exchange for options to purchase shares of common stock of Evofem Operations. Each option to purchase one share of common stock of Evofem Operations was cancelled and exchanged for the right to receive an option to purchase 0.154 shares of common stock of Issuer. The shares of common stock of Issuer exercisable pursuant to the option reported reflect any necessary adjustments to account for the 6 for 1 reverse stock split effected by Issuer on January 17, 2018.

F2 · price: These options to purchase common stock of Issuer were received in connection with the Merger in exchange for options to purchase shares of common stock of Evofem Operations. Each option to purchase one share of common stock of Evofem Operations was cancelled and exchanged for the right to receive an option to purchase 0.154 shares of common stock of Issuer. The shares of common stock of Issuer exercisable pursuant to the option reported reflect any necessary adjustments to account for the 6 for 1 reverse stock split effected by Issuer on January 17, 2018.

F3 · derivative.exercise_date: Mr. Barrans acquired a vested interest in twenty-five percent (25%) of the shares of common stock exercisable pursuant to the option effective as of September 28, 2016 (the "Vesting Start Date"). The remaining shares shall vest in a series of thirty-six (36) successive equal monthly installments on the monthly anniversary of the Vesting Start Date, such that all shares of common stock of Issuer exercisable pursuant to the option shall be fully vested on September 28, 2019, subject to Mr. Barrans' continued service.